Seth Loring Harrison, Director, Ten Percent Owner at Eledon Pharmaceuticals, holds 284.36K shares in Akero Therapeutics (Ticker: AKRO), holds 17.16M shares in Stoke Therapeutics (Ticker: STOK), holds 154.58K shares in HeartWare International (Ticker: HTWR). Most recently, Seth Loring Harrison Sold ― shares of Akero Therapeutics on Dec 02, 2022 for an estimated value of 1.09M.
What is the percentage of profitable transactions made by Seth Loring Harrison?
The percentage of profitable transactions made by Seth Loring Harrison is 44%.
What is the average return per transaction made by Seth Loring Harrison?
The average return per transaction made by Seth Loring Harrison is 9.50%.
What stocks does Seth Loring Harrison hold?
Seth Loring Harrison holds: ELDN, STOK, AKRO, HTWR stocks.
What was Seth Loring Harrison’s latest transaction?
Seth Loring Harrison latest transaction was an Informative Sell of $1.09M.
What was Seth Loring Harrison's most profitable transaction?
Seth Loring Harrison’s most profitable transaction was an Informative Sell of AKRO stock on October 27, 2022. The return on the trade was 72.20%.
What is Seth Loring Harrison's role in Eledon Pharmaceuticals?
Seth Loring Harrison's role in Eledon Pharmaceuticals is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.